Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
• To evaluate the effect of vildagliptin on left ventricular function in patients with T2DM and CHF (NYHA class I-III) by showing that vildagliptin is at least not inferior to placebo with respect to change in left ventricular ejection fraction (LVEF) after 52 weeks of treatment.
Inclusion criteria
- Type 2 Diabetes